KLA578-1

· Sichuan Kelun Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KLA578-1, covering 2025-08-27 to 2025-08-27. Get the full timeline:

Most recent: Clinical Trial Update: First-in-Human Single and Multiple Dose of KLA578-1 for Injection [Phase 1]